Shiji Fang | Medicine | Best Researcher Award

Published on by Research Hypothesis

Best Researcher Award

Shiji Fang
Lishui Central Hospital, China

Shiji Fang
Affiliation Lishui Central Hospital
Country China
Scopus ID 57192204982
Documents 91
Citations 2,574
h-index 27
Subject Area Medicine
Event International Research Hypothesis Excellence Award
ORCID 0009-0004-4998-5039

Shiji Fang is a medical researcher affiliated with Lishui Central Hospital in China whose indexed research profile reflects sustained scholarly activity in biomedical and translational medicine. The available Scopus-derived profile records 91 documents, 2,574 citations and an h-index of 27, indicating a substantial body of indexed research and citation activity. [1][2]

Abstract

Shiji Fang’s research profile is situated within medicine and includes a substantial body of indexed scholarly work. The supplied publication record highlights research at the intersection of cancer biology, tumor microenvironment, immunotherapy and nanomedicine. Recent studies address mechanisms and therapeutic approaches involving immunogenic cell death, reactive oxygen species, endoplasmic reticulum stress, cellular senescence, copper homeostasis, ferroptosis, cuproptosis, chemoembolization and MRI-guided therapeutic systems. [1] [2]

Keywords

Shiji Fang; Best Researcher Award; Medicine; cancer research; hepatocellular carcinoma; immunotherapy; nanomedicine; immunogenic cell death; ferroptosis; cuproptosis; tumor biology; therapeutic delivery; translational medicine; oxidative stress; endoplasmic reticulum stress.

Introduction

Contemporary cancer research increasingly integrates molecular oncology with materials science, immunology and targeted therapeutic delivery. Hepatocellular carcinoma in particular presents a complex therapeutic environment in which tumor heterogeneity, immune suppression and resistance mechanisms can limit treatment effectiveness. Research that investigates interactions among tumor cells, immune pathways and therapeutic nanoplatforms therefore forms an important component of translational biomedical investigation.[2] [3]

Research Profile

The supplied Scopus profile identifies Shiji Fang with Author ID 57192204982 and lists Lishui Central Hospital, China, as the institutional affiliation. The profile is associated with the subject area of Medicine and records 91 indexed documents, 2,574 citations and an h-index of 27. [1]

Research characteristics

  • Primary discipline: Medicine.
  • Institutional affiliation: Lishui Central Hospital, China.
  • Scopus Author ID: 57192204982.
  • Indexed documents: 91.
  • Reported citations: 2,574.
  • Reported h-index: 27.
  • Major themes represented: cancer biology, hepatocellular carcinoma, immunotherapy, nanomedicine and regulated cell-death mechanisms.

Research Contributions

The supplied publications indicate several connected areas of research contribution. One strand examines how natural or bioactive compounds can influence cancer-cell death and stress-response pathways. The 2025 article on astragalin investigates immunogenic cell death in liver cancer in connection with NQO2, reactive oxygen species and endoplasmic reticulum stress. [2]

A second strand concerns the integration of cellular senescence with immune activation. The study published in Advanced Science describes a biomimetic nanomedicine approach designed around senescence-modulated immune activation and its potential relationship with immunotherapy efficacy in hepatocellular carcinoma. [3]

Publications

The following selected publications are taken from the supplied Scopus-derived research information. The list emphasizes recent 2025 articles and includes DOI identifiers where provided.

  1. Astragalin induces immunogenic cell death in liver cancer by targeting NQO2 to promote ROS-mediated endoplasmic reticulum stress pathway. Free Radical Biology and Medicine.
  2. Biomimetic Nanomedicine for Senescence-Modulated Immune Activation Enhances Immunotherapy Efficacy in Hepatocellular Carcinoma. Advanced Science.
  3. Cascade-targeting copper homeostasis nano-regulators for mild-photothermal boosted cuproptosis/ferroptosis mediated breast cancer therapy. Journal of Nanobiotechnology.
  4. Corrigendum to “Fangchinoline inhibits metastasis and reduces inflammation-induced epithelial-mesenchymal transition by targeting the FOXM1-ADAM17 axis in hepatocellular carcinoma”. Cellular Signalling.

Research Impact

The supplied bibliometric indicators provide a quantitative view of the visibility of the research record. With 2,574 reported citations and an h-index of 27 across 91 indexed documents, the profile demonstrates sustained citation activity within the indexed scholarly literature. [1] Bibliometric measures should nevertheless be interpreted alongside publication quality, methodological rigor, authorship contributions and the substantive influence of individual studies.

Award Suitability

The Best Researcher Award within the International Research Hypothesis Excellence Award framework can be assessed using evidence concerning research productivity, scholarly visibility, thematic contribution and relevance to the broader research community. The supplied profile provides several measurable indicators, including 91 indexed documents, 2,574 citations and an h-index of 27. [1]

Conclusion

Shiji Fang’s supplied academic profile presents an established research record in Medicine, with affiliation to Lishui Central Hospital in China and a Scopus Author ID of 57192204982. The reported 91 documents, 2,574 citations and h-index of 27 provide quantitative indicators of scholarly activity and citation visibility. [1]

References

  1. Elsevier. (n.d.). Scopus author details: Shiji Fang, Author ID 57192204982. Scopus.
    https://www.scopus.com/pages/authors/57192204982
  2. Zheng, L., Zhao, Z., Chen, L., Yang, W., Ercolani, G., Qin, P., Lin, B., Han, M., Weng, Q., Zhang, Y., et al. (2025). Astragalin induces immunogenic cell death in liver cancer by targeting NQO2 to promote ROS-mediated endoplasmic reticulum stress pathway. Free Radical Biology and Medicine.
    https://doi.org/10.1016/j.freeradbiomed.2025.07.047
  3. Fang, S., Zheng, L., Lin, B., Chen, J., Hou, D., Ding, Y., Han, M., Qin, P., Wang, M., Guo, X., et al. (2025). Biomimetic Nanomedicine for Senescence-Modulated Immune Activation Enhances Immunotherapy Efficacy in Hepatocellular Carcinoma. Advanced Science.
    https://doi.org/10.1002/advs.202517792
  4. Liang, X., Fang, S., Xin, Y., Lei, J., Wang, W., Wei, Y., Li, W., Li, C., Tang, H., Wei, X., et al. (2025). Cascade-targeting copper homeostasis nano-regulators for mild-photothermal boosted cuproptosis/ferroptosis mediated breast cancer therapy. Journal of Nanobiotechnology.
    https://doi.org/10.1186/s12951-025-03722-2
  5. Chen, M., Chen, Y., Chen, W., Chen, X., Guo, X., Yu, J., Guo, X., Wang, M., Zhang, X., Hu, Q., et al. (2025). Immune-activated microspheres for enhanced chemoembolization of hepatocellular carcinoma by blocking the adenosine A2A receptor. Acta Biomaterialia.
    https://doi.org/10.1016/j.actbio.2025.04.042
  6. Chen, X., Zhang, F., Lu, C., Wu, R., Yang, et al. (2025). Lactate-Fueled Theranostic Nanoplatforms for Enhanced MRI-Guided Ferroptosis Synergistic with Immunotherapy of Hepatocellular Carcinoma. ACS Applied Materials and Interfaces.
    https://doi.org/10.1021/acsami.4c21890

Aya EL-Taibany | Medicine | Best Researcher Award

Published on by Research Hypothesis

Best Researcher Award

Aya EL-Taibany

Wake Forest Institute for Regenerative Medicine

               Aya EL-Taibany
Affiliation Wake Forest Institute for Regenerative Medicine
Country United States
Scopus ID 57217169106
Documents 4
Citations 117
h-index 4
Subject Area Medicine
Event International Research Hypothesis Excellence Award

Aya EL-Taibany is affiliated with the Wake Forest Institute for Regenerative Medicine in the United States and has contributed to scholarly research in the field of medicine, particularly in areas associated with regenerative medicine and translational biomedical science. The available bibliometric indicators, including a Scopus profile comprising four indexed publications and more than one hundred citations, demonstrate a focused research trajectory and measurable scientific influence within a specialized domain.[1]

Abstract

This academic profile summarizes the research activities and scholarly contributions of Aya EL-Taibany, a researcher associated with the Wake Forest Institute for Regenerative Medicine. Bibliometric evidence indicates meaningful contributions within medical and regenerative sciences through peer-reviewed publications and measurable citation performance. The profile further evaluates the relevance of these contributions in relation to the criteria commonly associated with scientific excellence awards and recognition programs.[1]

Keywords

Aya EL-Taibany; Regenerative Medicine; Translational Medicine; Biomedical Research; Scientific Publications; Citation Analysis; Medical Sciences; Research Excellence; Best Researcher Award.

Introduction

Regenerative medicine represents one of the most rapidly evolving areas of contemporary biomedical research, integrating principles from biology, engineering, and clinical sciences to develop innovative therapeutic approaches. Researchers working in this domain contribute to advancing knowledge related to tissue regeneration, disease mechanisms, and translational applications. The academic profile of Aya EL-Taibany reflects engagement with these interdisciplinary scientific themes and demonstrates participation in research activities that support the progression of modern medicine.[3]

Research Profile

Aya EL-Taibany is affiliated with the Wake Forest Institute for Regenerative Medicine in the United States and maintains a documented publication record indexed within major scientific databases. Available bibliometric indicators identify four indexed documents, 117 citations, and an h-index of four, suggesting that the published works have achieved scholarly visibility and influence within relevant research communities.[1]

Research Contributions

The available scientific record indicates contributions to medical and regenerative research through publications addressing translational science and biomedical innovation. Such studies contribute to the understanding of biological processes and support the development of therapeutic strategies designed to improve patient outcomes and expand scientific knowledge.[2]

Publications

The publication portfolio indexed under the author’s Scopus profile demonstrates focused scholarly productivity and reflects contributions to peer-reviewed medical research. Indexed documents have accumulated a significant number of citations relative to the size of the publication record, indicating the relevance and visibility of the published studies within their research fields.[1]

Research Impact

Citation metrics serve as an important indicator of the dissemination and influence of scientific research. The citation profile associated with Aya EL-Taibany demonstrates that the published works have attracted sustained scholarly attention and have contributed to ongoing academic discussions within medicine and regenerative sciences. The relationship between publication quality and citation impact further supports the recognition of these contributions within the broader scientific community.[4]

Award Suitability

The criteria commonly associated with the International Research Hypothesis Excellence Award emphasize scientific originality, measurable research impact, and contributions that advance academic and societal understanding. Aya EL-Taibany’s scholarly profile demonstrates characteristics that align with these principles, including peer-reviewed publications, citation performance, and involvement in innovative biomedical research activities. Such attributes support consideration for recognition within international research award programs.[2]

Conclusion

Aya EL-Taibany’s academic profile reflects a focused contribution to medicine and regenerative research through publications that have achieved meaningful scholarly visibility. Bibliometric indicators and institutional affiliation provide evidence of sustained scientific engagement and support the relevance of this work within contemporary biomedical research. Recognition through academic excellence programs is consistent with the demonstrated impact and quality of the documented research contributions.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Aya EL-Taibany, Author ID 57217169106. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57217169106
  2. International Research Hypothesis. (n.d.). International Research Hypothesis Excellence Award.
    https://researchhypothesis.com/
  3. Mason, C., Dunnill, P. (2008). A brief definition of regenerative medicine. Regenerative Medicine, 3(1), 1–5.
  4. Hirsch, J. E. (2005). An index to quantify an individual’s scientific research output. Proceedings of the National Academy of Sciences, 102(46), 16569–16572.
  5. Nzou, G., Wicks, R. T., VanOstrand, N. R., Mekky, G. A., Seale, S. A., El-Taibany, A., … Atala, A. (2020). Multicellular 3D neurovascular unit model for assessing hypoxia and neuroinflammation induced blood-brain barrier dysfunction.